Hyderabad-based Bharat Biotech International Ltd. (BBIL), co-founded by Krishna Ella and wife Suchitra, came into the limelight when it developed and produced Covaxin to fight the pandemic. The company produces 4 crore doses a month. Covaxin was recently approved by regulators for use in children between 2 and 18 years. "Krishna and I work out of our campus, which is 75 kilometres from our residence. We felt that our presence in the midst of our colleagues would give a lot of strength," says Suchitra. While her husband has looked after the scientific aspects, Suchitra has worked behind the scenes — from sourcing land to writing letters to the Ministry of Science and Technology. "Being physically present in the campus I was involved in everything" says Suchitra. — Anshul Dhamija